Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Quantitative Affinity Determination by Fluorescence Anisotropy Measurements of Individual Nanoliter Droplets.

Gielen F, Butz M, Rees EJ, Erdelyi M, Moschetti T, Hyvönen M, Edel JB, Kaminski CF, Hollfelder F.

Anal Chem. 2017 Jan 17;89(2):1092-1101. doi: 10.1021/acs.analchem.6b02528.

2.

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

Luo K, Li L, Li Y, Wu C, Yin Y, Chen Y, Deng M, Nowsheen S, Yuan J, Lou Z.

Genes Dev. 2016 Dec 1;30(23):2581-2595. doi: 10.1101/gad.289439.116.

PMID:
27941124
3.

A Polar and Nucleotide-Dependent Mechanism of Action for RAD51 Paralogs in RAD51 Filament Remodeling.

Taylor MR, Špírek M, Jian Ma C, Carzaniga R, Takaki T, Collinson LM, Greene EC, Krejci L, Boulton SJ.

Mol Cell. 2016 Dec 1;64(5):926-939. doi: 10.1016/j.molcel.2016.10.020.

4.

Rad51 and RecA juxtapose dsDNA ends ready for DNA ligase-catalyzed end-joining under recombinase-suppressive conditions.

Konomura N, Arai N, Shinohara T, Kobayashi J, Iwasaki W, Ikawa S, Kusano K, Shibata T.

Nucleic Acids Res. 2017 Jan 9;45(1):337-352. doi: 10.1093/nar/gkw998.

5.

Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer.

Wang Y, Mark KM, Ung MH, Kettenbach A, Miller T, Xu W, Cheng W, Xia T, Cheng C.

Genome Med. 2016 Oct 27;8(1):114.

6.

Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51.

Moschetti T, Sharpe T, Fischer G, Marsh ME, Ng HK, Morgan M, Scott DE, Blundell TL, R Venkitaraman A, Skidmore J, Abell C, Hyvönen M.

J Mol Biol. 2016 Nov 20;428(23):4589-4607. doi: 10.1016/j.jmb.2016.10.009.

7.

FANCI-FANCD2 stabilizes the RAD51-DNA complex by binding RAD51 and protects the 5'-DNA end.

Sato K, Shimomuki M, Katsuki Y, Takahashi D, Kobayashi W, Ishiai M, Miyoshi H, Takata M, Kurumizaka H.

Nucleic Acids Res. 2016 Dec 15;44(22):10758-10771.

8.

Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine.

Murata S, Zhang C, Finch N, Zhang K, Campo L, Breuer EK.

Biomed Res Int. 2016;2016:2346585. doi: 10.1155/2016/2346585. Review.

9.

High-resolution structure of the presynaptic RAD51 filament on single-stranded DNA by electron cryo-microscopy.

Short JM, Liu Y, Chen S, Soni N, Madhusudhan MS, Shivji MK, Venkitaraman AR.

Nucleic Acids Res. 2016 Nov 2;44(19):9017-9030.

10.

The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.

Mehrgou A, Akouchekian M.

Med J Islam Repub Iran. 2016 May 15;30:369. Review.

11.

ATP half-sites in RadA and RAD51 recombinases bind nucleotides.

Marsh ME, Scott DE, Ehebauer MT, Abell C, Blundell TL, Hyvönen M.

FEBS Open Bio. 2016 Apr 6;6(5):372-85. doi: 10.1002/2211-5463.12052.

12.

Roles of C-Terminal Region of Yeast and Human Rad52 in Rad51-Nucleoprotein Filament Formation and ssDNA Annealing.

Khade NV, Sugiyama T.

PLoS One. 2016 Jun 30;11(6):e0158436. doi: 10.1371/journal.pone.0158436.

13.
14.

RAD51 variant proteins from human lung and kidney tumors exhibit DNA strand exchange defects.

Silva MC, Morrical MD, Bryan KE, Averill AM, Dragon J, Bond JP, Morrical SW.

DNA Repair (Amst). 2016 Jun;42:44-55. doi: 10.1016/j.dnarep.2016.02.008.

PMID:
27153211
15.

Role of the RAD51-SWI5-SFR1 Ensemble in homologous recombination.

Su GC, Yeh HY, Lin SW, Chung CI, Huang YS, Liu YC, Lyu PC, Chi P.

Nucleic Acids Res. 2016 Jul 27;44(13):6242-51. doi: 10.1093/nar/gkw375.

16.

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity.

Chatterjee G, Jimenez-Sainz J, Presti T, Nguyen T, Jensen RB.

Nucleic Acids Res. 2016 Jun 20;44(11):5256-70. doi: 10.1093/nar/gkw242.

17.

Involvement of budding yeast Rad5 in translesion DNA synthesis through physical interaction with Rev1.

Xu X, Lin A, Zhou C, Blackwell SR, Zhang Y, Wang Z, Feng Q, Guan R, Hanna MD, Chen Z, Xiao W.

Nucleic Acids Res. 2016 Jun 20;44(11):5231-45. doi: 10.1093/nar/gkw183.

18.

Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction.

Scott DE, Marsh M, Blundell TL, Abell C, Hyvönen M.

FEBS Lett. 2016 Apr;590(8):1094-102. doi: 10.1002/1873-3468.12139.

19.

BRCA2 regulates DMC1-mediated recombination through the BRC repeats.

Martinez JS, von Nicolai C, Kim T, Ehlén Å, Mazin AV, Kowalczykowski SC, Carreira A.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3515-20. doi: 10.1073/pnas.1601691113.

20.

DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.

Velic D, Couturier AM, Ferreira MT, Rodrigue A, Poirier GG, Fleury F, Masson JY.

Biomolecules. 2015 Nov 20;5(4):3204-59. doi: 10.3390/biom5043204. Review.

Supplemental Content

Support Center